On the front lines of Kaiser Permanente’s pandemic response, infectious disease leaders play a key role in sharing research, building guidelines, and charting a national roadmap to flatten the coronavirus curve.
A new study led by Permanente physician-researchers found young people felt more comfortable talking about gender identity issues when asked first by a clinician.
In interviews with the American Medical Association, The Permanente Federation co-CEO discusses the importance of contact tracing and Kaiser Permanente’s $63 million commitment to assist local health departments.
In an interview with the New York Times, Rebecca Boxer, MD, discusses how a new clinical trial will serve a population greatly in need of targeted COVID-19 treatments.
A study published in the New England Journal of Medicine, led by Lisa A. Jackson, MD, of Kaiser Permanente’s Washington Health Research Institute, reports on promising results in the phase 1 trial of an experimental COVID-19 vaccine.
Collaboration between Kaiser Permanente’s care delivery system and research programs has driven the successful implementation of remdesivir clinical trials across regions.
Greg Simon, MD, MPH, a psychiatrist with Washington Permanente Medical Group, told Health that situational depression occurs after a life event – such as job loss, death of a loved one, or serious illness diagnosis – that leaves the person feeling stressed or upset.
Imelda Dacones, MD, president and CEO of Northwest Permanente, says physicians have an obligation to reduce the causes and mitigate the effects of climate change.
To provide the best experience, we use cookies to store and/or access device information, and to process data such as browsing behavior or unique IDs. Please click Accept to give us permission to personalize content and enable analytics. Note that opting out may adversely affect your access to certain features and functions, such as video and audio playback.
Functional
Always active
These cookies are essential for the site to function. The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.These cookies allow us to gather nonidentifiable information such as number of site visits. The technical storage or access is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
These cookies can be used to provide you with relevant advertisements, although we do not typically target users with ads. The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.